Literature DB >> 23500067

Left ventricular hypertrophy caused by a novel nonsense mutation in FHL1.

Thomas D Gossios1, Luis R Lopes, Perry M Elliott.   

Abstract

Emery Dreifuss muscular dystrophy (EDMD) is a hereditary muscular disorder, characterized by contractures, progressive muscular wasting and cardiac involvement. The majority of EDMD patients harbor mutations in the lamin A/C (LMNA) and emerin (STA) genes. Emerging data implicate mutations in FHL1 (four and a half LIM protein 1) gene, located in chromosome Xq26, in EDMD pathogenesis. FHL1 is mainly expressed in striated and cardiac muscle, and plays an important role in sarcomeric protein synthesis, maintenance of cellular integrity, intracellular signaling and genetic transcription pathways. We report the identification of a novel nonsense mutation in FHL1 gene, associated with left ventricular hypertrophy and a family history of stroke and sudden cardiac death. The management implications of this diagnosis are also discussed.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23500067     DOI: 10.1016/j.ejmg.2013.03.001

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  10 in total

Review 1.  Four and a half LIM domain protein signaling and cardiomyopathy.

Authors:  Yan Liang; William H Bradford; Jing Zhang; Farah Sheikh
Journal:  Biophys Rev       Date:  2018-06-20

2.  Fhl1 W122S causes loss of protein function and late-onset mild myopathy.

Authors:  Valentina Emmanuele; Akatsuki Kubota; Beatriz Garcia-Diaz; Caterina Garone; Hasan O Akman; Daniel Sánchez-Gutiérrez; Luis M Escudero; Shingo Kariya; Shunichi Homma; Kurenai Tanji; Catarina M Quinzii; Michio Hirano
Journal:  Hum Mol Genet       Date:  2014-09-30       Impact factor: 6.150

3.  FHL1-related clinical, muscle MRI and genetic features in six Chinese patients with reducing body myopathy.

Authors:  ZhenXian Hu; Ying Zhu; Xiao Liu; Wei Zhang; Jing Liu; Shiwen Wu; Jiangxi Xiao; Yun Yuan; Zhaoxia Wang
Journal:  J Hum Genet       Date:  2019-07-04       Impact factor: 3.172

Review 4.  Understanding the molecular basis of cardiomyopathy.

Authors:  Marie-Louise Bang; Julius Bogomolovas; Ju Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-19       Impact factor: 5.125

Review 5.  The sarcomeric M-region: a molecular command center for diverse cellular processes.

Authors:  Li-Yen R Hu; Maegen A Ackermann; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Biomed Res Int       Date:  2015-04-15       Impact factor: 3.411

6.  HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress.

Authors:  Liyong Zhang; Xin Chen; Parveen Sharma; Mark Moon; Alex D Sheftel; Fayez Dawood; Mai P Nghiem; Jun Wu; Ren-Ke Li; Anthony O Gramolini; Poul H Sorensen; Josef M Penninger; John H Brumell; Peter P Liu
Journal:  Nat Commun       Date:  2014-03-11       Impact factor: 14.919

Review 7.  Heart Disease in Disorders of Muscle, Neuromuscular Transmission, and the Nerves.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

Review 8.  Emery-Dreifuss muscular dystrophy: a test case for precision medicine.

Authors:  De-Ann M Pillers; Nicholas H Von Bergen
Journal:  Appl Clin Genet       Date:  2016-02-24

9.  Molecular autopsy and family screening in a young case of sudden cardiac death reveals an unusually severe case of FHL1 related hypertrophic cardiomyopathy.

Authors:  Anna Gaertner-Rommel; Jens Tiesmeier; Thomas Jakob; Bernd Strickmann; Gunter Veit; Bernd Bachmann-Mennenga; Lech Paluszkiewicz; Karin Klingel; Uwe Schulz; Kai T Laser; Bernd Karger; Heidi Pfeiffer; Hendrik Milting
Journal:  Mol Genet Genomic Med       Date:  2019-07-10       Impact factor: 2.183

10.  Three novel FHL1 variants cause a mild phenotype of Emery-Dreifuss muscular dystrophy.

Authors:  Josefine D S Borch; Thomas Krag; Sonja D Holm-Yildiz; Hakan Cetin; Tuva A Solheim; Freja Fornander; Volker Straub; Morten Duno; John Vissing
Journal:  Hum Mutat       Date:  2022-07-16       Impact factor: 4.700

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.